Mehadrin EPS
The Earnings per Share (EPS) of Mehadrin (MEDN.TA) as of Oct 3, 2026 is 37.86 ILS. In the previous year, Earnings per Share (EPS) was -19.89 ILS — a change of -290.35% (higher).
Get this data via API
Financial Data API
EPS
37.86ILS
YoY
-290.35%
Last updated:
The Mehadrin EPS history
3 Years
10 Years
25 Years
Max
| YEAR | EPS | YoY |
|---|---|---|
| 37.86ILS | -290.35% | |
| -19.89ILS | -57.30% | |
| -46.58ILS | +83.95% | |
| -25.32ILS | -160.43% | |
| 41.91ILS | +4,757.68% | |
| 0.86ILS | -80.60% | |
| 4.45ILS | -57.41% | |
| 10.44ILS | -38.70% | |
| 17.03ILS | +81.60% | |
| 9.38ILS | +489.67% | |
| 1.59ILS | -208.61% | |
| -1.46ILS | -119.90% | |
| 7.36ILS | -50.33% | |
| 14.82ILS | +79.43% | |
| 8.26ILS | -47.85% | |
| 15.84ILS | +2.75% | |
| 15.41ILS | +24.70% | |
| 12.36ILS | -28.19% | |
| 17.21ILS | +165.40% | |
| 6.48ILS | — |
Mehadrin Stock analysis
Frequently Asked Questions about Mehadrin stock
Earnings per Share (EPS) of Mehadrin is 37.86 ILS in 2026.
Earnings per Share (EPS) of Mehadrin changed from -19.89 ILS to 37.86 ILS, representing a -290.35% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Mehadrin since 2006 – with annual values, charts, and detailed analysis.
Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.
EPS = Net Income / Shares Outstanding
Income Statement — Mehadrin
All Key Metrics — Mehadrin
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth